Filed: 1/31/2023ACC: 0000950123-23-000484
📋 What this filing means
INTERWEST VENTURE MANAGEMENT CO filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $20.80M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$20.80M
Total AUM (reported)
6.46M
Total Shares
Allocation by class
COM$17.76M85.4%
CLASS A COM$3.04M14.6%
Portfolio Concentration
Top 3$20.04M96.3%
4–10$765.6K3.7%
Top 3 weight
96.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 6.46M
Sole
Full voting authority
6.46M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
PMV PHARMACEUTICALS INC
SOLEShares1.61M
TypeSH
Market value$14.05M
67.54%
Sole
1.61M
Shared
0.00
None
0.00
SERA PROGNOSTICS
SOLEShares2.42M
TypeSH
Market value$3.04M
14.64%
Sole
2.42M
Shared
0.00
None
0.00
THE REALREAL
SOLEShares2.35M
TypeSH
Market value$2.94M
14.15%
Sole
2.35M
Shared
0.00
None
0.00
GLAUKOS CORP
SOLEShares16.35K
TypeSH
Market value$714.0K
3.43%
Sole
16.35K
Shared
0.00
None
0.00
DARE BIOSCIENCE INC
SOLEShares62.06K
TypeSH
Market value$51.5K
0.25%
Sole
62.06K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PMV PHARMACEUTICALS INCSOLE | COM | 1.61M | SH | $14.05M 67.54% | 1.61M | 0.00 | 0.00 |
SERA PROGNOSTICSSOLE | CLASS A COM | 2.42M | SH | $3.04M 14.64% | 2.42M | 0.00 | 0.00 |
THE REALREALSOLE | COM | 2.35M | SH | $2.94M 14.15% | 2.35M | 0.00 | 0.00 |
GLAUKOS CORPSOLE | COM | 16.35K | SH | $714.0K 3.43% | 16.35K | 0.00 | 0.00 |
DARE BIOSCIENCE INCSOLE | COM | 62.06K | SH | $51.5K 0.25% | 62.06K | 0.00 | 0.00 |